Catalyst Wire Dossier Catalyst Wire Dossier

Elevidys

delandistrogene moxeparvovec · Roche Registration GmbH
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Elevidys, covering 2025-10-20 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Effectiveness of ELEVIDYS in Participants With Duchenne Muscular Dystrophy Treated in a Post-Marketing Setting [Phase 4]

See pricing